American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

Gespeichert in:
Autor*in:

Stolbach, Andrew I. [verfasserIn]

Mazer-Amirshahi, Maryann

Nelson, Lewis S.

Cole, Jon B.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2023

Schlagwörter:

Opioid overdose

Nalmefene

Naloxone

Intranasal

FDA Abbreviated New Drug Application

Anmerkung:

© American College of Medical Toxicology 2023. corrected publication 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Übergeordnetes Werk:

Enthalten in: Journal of medical toxicology - New York, NY : Springer, 2005, 20(2023), 1 vom: 30. Nov., Seite 64-67

Übergeordnetes Werk:

volume:20 ; year:2023 ; number:1 ; day:30 ; month:11 ; pages:64-67

Links:

Volltext

DOI / URN:

10.1007/s13181-023-00981-z

Katalog-ID:

SPR054311004

Nicht das Richtige dabei?

Schreiben Sie uns!